Showing 9711-9720 of 18563 results for "".
- Metabolic Perturbations in Children Post COVID-19: Unseen Cardiovascular Implicationshttps://reachmd.com/news/metabolic-perturbations-in-children-post-covid-19-unseen-cardiovascular-implications/2475197/Unexpected metabolic alterations in children recovering from COVID-19 are emerging as a concern and may suggest potential cardiovascular risks, although further research is needed to confirm these findings. The metabolic impact of
- Balancing Surgical Choices for Breast Cancer: Neoadjuvant Therapy Insightshttps://reachmd.com/news/balancing-surgical-choices-for-breast-cancer-neoadjuvant-therapy-insights/2475203/Decisions between breast-conserving surgery and mastectomy after neoadjuvant therapy are guided by data indicating comparable survival and recurrence outcomes for both approaches, aligning with established surgical guidelines. For surg
- The Impact of Beverage Choices on Parkinson’s Disease Managementhttps://reachmd.com/news/the-impact-of-beverage-choices-on-parkinsons-disease-management/2475206/Clinicians increasingly turn to lifestyle modifications, yet the impact of beverage consumption on Parkinson’s Disease management remains underrecognized, particularly when genetic and environmental factors diverge. As neurologists and
- Addressing Opioid-Induced Constipation in Pain Managementhttps://reachmd.com/news/addressing-opioid-induced-constipation-in-pain-management/2475185/Opioid-induced constipation remains a ubiquitous barrier to effective pain relief, yet emerging research offers concrete strategies to tailor prescriptions and mitigate this side effect. Opioid analgesics are the cornerstone of chronic
- Advancing Neurogenetic Research for Early Diagnosis and Intervention Strategies in Childrenhttps://reachmd.com/news/advancing-neurogenetic-research-for-early-diagnosis-and-intervention-strategies-in-children/2475178/The evolving landscape of pediatric neurological disorders poses significant challenges for clinicians as genetic underpinnings drive a spectrum of presentations, from intractable seizures to progressive motor decline. Exploring epilepsy genetics has uncovered the pivotal influence of l
- The Dawn of Immunotherapy in Head and Neck Cancer: Pembrolizumab's Rolehttps://reachmd.com/news/the-dawn-of-immunotherapy-in-head-and-neck-cancer-pembrolizumabs-role/2475186/Despite aggressive multimodal strategies, survival gains in locally advanced head and neck squamous cell carcinoma have been marginal, with reports indicating an average annual improvement of only 0.28%, highlighting the need for new therapeu
- Enhancing Oncologic Surgery Precision with Real-Time ICG Fluorescence Imaginghttps://reachmd.com/news/enhancing-oncologic-surgery-precision-with-real-time-icg-fluorescence-imaging/2475179/Oncologic surgeons performing salvage resection for recurrent nasopharyngeal carcinoma often grapple with the imprecise delineation of tumor margins using conventional imaging modalities, raising the risk of incomplete excisions and suboptima
- Enhancing mCRPC Imaging with Dual-Tracer and AI-Powered PSMA PET/CThttps://reachmd.com/news/enhancing-mcrpc-imaging-with-dual-tracer-and-ai-powered-psma-petct/2475180/Emerging imaging modalities are reshaping the evaluation of metastatic castration-resistant prostate cancer, with dual-tracer and AI-powered PSMA PET/CT advancing diagnostic precision beyond traditional approaches, although these technologies
- The Impact of Environmental Metal Exposure on Metabolic Syndromehttps://reachmd.com/news/the-impact-of-environmental-metal-exposure-on-metabolic-syndrome/2475184/Environmental exposures, particularly chronic metal contamination, are associated with an increased risk of metabolic syndrome, highlighting the need for renewed attention from endocrino
- Immunotherapy Combinations in Oncology: Expanding Boundarieshttps://reachmd.com/news/immunotherapy-combinations-in-oncology-expanding-boundaries/2475158/As immunotherapy is reshaping oncology, oncologists are leveraging combination therapies to push treatment boundaries and enhance patient outcomes. Combining immunotherapy with targeted therapies has been shown to